Dr. Isha Gambhir is a Hemato-Oncology and Bone Marrow Transplant (BMT) specialist with extensive experience in managing complex blood cancers, acute leukemias, and transplant patients. She has been involved in the care of 500+ bone marrow transplants, including Autologous, Allogeneic, Haploidentical, and Matched Unrelated Donor (MUD) transplants. Her clinical expertise also includes CAR-T cell therapy, immunotherapies, targeted therapies, and the management of immunocompromised patients on high-dose chemotherapy. Dr. Gambhir is academically active with multiple international conference presentations, peer-reviewed publication, and participation as Co-Principal Investigator in multi-center clinical trials.

Dr. Isha
Associate Consultant - (Haemato-Oncology & BMT)
Oncology
Qualification:
MBBS, FIIM, PGD
Experience:7+ Years
Rating:Patient Satisfaction Rate: 5 | Rating: 5/5 ⭐
Languages:English, Hindi
About
Experience
- Junior Resident MSP & Medical ICU.
- Clinical Practice.
- Attending Consultant.
Awards & Achievements
- Abstract selected for publication at EHA 2025 (Milan, Italy)
- Poster presentations at major international forums: EHA 2020, EBMT 2020, ASH 2021, EBMT 2024
- Peer-reviewed publication in Leukaemia & Lymphoma (2021) on a rare myeloma-related coagulopathy topic
Specialization & Expertise
- Blood cancers (Hemato-oncology)
- Bone Marrow Transplant: Autologous, Allogeneic, Haploidentical, MUD
- Care of immunocompromised patients (post-BMT, acute leukemia on chemotherapy)
- Immunotherapy & targeted therapy handling
- CAR-T cell therapy experience
Qualifications
- MBBS
- FIIM (Medicine)
- PGD- Haematology
- Fellowship- HemOnc and BMT
Clinical Interests
- Hemato-Oncology (Blood Cancers) – leukemia, lymphoma, multiple myeloma
- Bone Marrow Transplant (BMT) – Autologous, Allogeneic, Haploidentical & MUD transplants
- Acute Leukemia Management – induction chemotherapy and high-dose regimens
- Post-Transplant Care – management of complications and long-term follow-up
- Immunocompromised Patient Care – high-risk infections and supportive care
- CAR-T Cell Therapy – clinical exposure and patient care support
- Targeted Therapy & Immunotherapy – planning and monitoring advanced treatments
- Clinical Research & Trials – participation in multi-center hematology/oncology studies
Research
N/A
Memberships
- European Haematology Association (EHA)
Our Medical Experts

Dr. Pawan Kumar Singh
Vice Chairman - (Haemato-Oncology & BMT)
Oncology
Experience: 15+ Years

Dr. Hemkant Verma
Consultant - (Surgical Oncology)
Oncology
Experience: 12+ Years

Dr. Anil Thakwani
Senior Consultant & H.O.D - (Radiation Oncology)
Oncology
Experience: 25+ Years

Dr. Gulafshan Jabi
Senior Resident - (Radiation Oncologist)
Oncology
Experience: 8+ Years

Dr. Swarnita Sahu
Associate Consultant - (Radiation Oncology)
Oncology
Experience: 5+ Years

Dr. Anindya Mukherjee
Senior Consultant - (Medical Oncology)
Oncology
Experience: 12+ Years

